DexCom financials
$86.64−0.05%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718.5M | $573.3M |
| Gross profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $931.5M | $663.9M | $492.1M | $378.4M |
| Gross margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | 68.5% | 66.0% |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M | $265.8M | $299.5M | $142.3M | -$186.3M | -$42.5M | -$63.9M |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M | $216.9M | $549.7M | $101.1M | -$127.1M | -$50.2M | -$65.6M |
| Net margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | 28.5% | 6.8% | −12.3% | −7.0% | −11.4% |
| Diluted EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $0.07 | $-0.09 | $-0.04 | $-0.05 |
| EBITDA | $1.16B | $817.7M | $783.7M | $547.1M | $367.8M | $366.6M | $191.0M | -$157.2M | -$26.4M | -$48.9M |
| Operating cash flow | $1.44B | $989.5M | $748.5M | $669.5M | $442.5M | $475.6M | $314.5M | $123.2M | $92.0M | $56.2M |
| Free cash flow | $1.08B | $630.7M | $511.9M | $304.7M | $53.3M | $276.6M | $134.5M | $56.1M | $26.0M | $500.0K |
| Diluted shares | 405.5M | 412.7M | 425.5M | 427.5M | 428.8M | 420.4M | 1,476.8M | 1,411.2M | 1,380.8M | 1,337.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.05B | $817.6M |
| Short-term investments | $1.08B | $1.97B | $2.16B | $1.81B | $1.68B | $1.89B |
| Total debt | $1.24B | $2.44B | $2.43B | $1.97B | $1.98B | $1.67B |
| Total assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B |
| Total liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B |
| Shareholders' equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.83B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology